{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T07:37:41Z","timestamp":1759563461423},"reference-count":52,"publisher":"Spandidos Publications","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.3892\/or.2017.5903","type":"journal-article","created":{"date-parts":[[2017,8,14]],"date-time":"2017-08-14T05:11:24Z","timestamp":1502687484000},"page":"1985-1994","source":"Crossref","is-referenced-by-count":13,"title":["TP63 mutations are frequent in cutaneous melanoma, support UV etiology, but their role in melanomagenesis is unclear"],"prefix":"10.3892","volume":"38","author":[{"given":"Paola","family":"Monti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola","family":"Ghiorzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola","family":"Menichini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giorgia","family":"Foggetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola","family":"Queirolo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Izzotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gilberto","family":"Fronza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2017,8,14]]},"reference":[{"key":"key20180107220231_b1-or-38-04-1985","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/278261a0","article-title":"T antigen is bound to a host protein in SV40-transformed cells","volume":"278","author":"Lane","year":"1979","journal-title":"Nature"},{"key":"key20180107220231_b2-or-38-04-1985","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/S0092-8674(00)80540-1","article-title":"Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers","volume":"90","author":"Kaghad","year":"1997","journal-title":"Cell"},{"key":"key20180107220231_b3-or-38-04-1985","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S1097-2765(00)80275-0","article-title":"p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities","volume":"2","author":"Yang","year":"1998","journal-title":"Mol Cell"},{"key":"key20180107220231_b4-or-38-04-1985","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1002\/humu.22514","article-title":"TP53 mutants in the tower of babel of cancer progression","volume":"35","author":"Bisio","year":"2014","journal-title":"Hum Mutat"},{"key":"key20180107220231_b5-or-38-04-1985","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1038\/cdd.2010.35","article-title":"p53-family proteins and their regulators: Hubs and spokes in tumor suppression","volume":"17","author":"Collavin","year":"2010","journal-title":"Cell Death Differ"},{"key":"key20180107220231_b6-or-38-04-1985","doi-asserted-by":"crossref","first-page":"687359","DOI":"10.1155\/2012\/687359","article-title":"p53 family: Role of protein isoforms in human cancer","volume":"2012","author":"Wei","year":"2012","journal-title":"J Nucleic Acids"},{"key":"key20180107220231_b7-or-38-04-1985","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1177\/1947601911413466","article-title":"Li-fraumeni syndrome","volume":"2","author":"Malkin","year":"2011","journal-title":"Genes Cancer"},{"key":"key20180107220231_b8-or-38-04-1985","doi-asserted-by":"crossref","first-page":"3789","DOI":"10.1158\/1078-0432.CCR-06-2545","article-title":"Transcriptional functionality of germ line p53 mutants influences cancer phenotype","volume":"13","author":"Monti","year":"2007","journal-title":"Clin Cancer Res"},{"key":"key20180107220231_b9-or-38-04-1985","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1158\/1541-7786.MCR-10-0496","article-title":"Dominant-negative features of mutant TP53 in germline carriers have limited impact on cancer outcomes","volume":"9","author":"Monti","year":"2011","journal-title":"Mol Cancer Res"},{"key":"key20180107220231_b10-or-38-04-1985","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/35003607","article-title":"p73-deficient mice have neurological, pheromonal and inflammatory defects but lack spontaneous tumours","volume":"404","author":"Yang","year":"2000","journal-title":"Nature"},{"key":"key20180107220231_b11-or-38-04-1985","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/19531","article-title":"p63 is a p53 homologue required for limb and epidermal morphogenesis","volume":"398","author":"Mills","year":"1999","journal-title":"Nature"},{"key":"key20180107220231_b12-or-38-04-1985","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1177\/1947601911408890","article-title":"p73 in Cancer","volume":"2","author":"Rufini","year":"2011","journal-title":"Genes Cancer"},{"key":"key20180107220231_b13-or-38-04-1985","doi-asserted-by":"crossref","first-page":"262","DOI":"10.4161\/cc.6.3.3796","article-title":"p63-associated disorders","volume":"6","author":"Rinne","year":"2007","journal-title":"Cell Cycle"},{"key":"key20180107220231_b14-or-38-04-1985","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1002\/humu.22304","article-title":"EEC- and ADULT-associated TP63 mutations exhibit functional heterogeneity toward P63 responsive sequences","volume":"34","author":"Monti","year":"2013","journal-title":"Hum Mutat"},{"key":"key20180107220231_b15-or-38-04-1985","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.ccr.2005.02.019","article-title":"Tumor predisposition in mice mutant for p63 and p73: Evidence for broader tumor suppressor functions for the p53 family","volume":"7","author":"Flores","year":"2005","journal-title":"Cancer Cell"},{"key":"key20180107220231_b16-or-38-04-1985","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0960-9822(00)00002-6","article-title":"Tumor spectrum analysis in p53-mutant mice","volume":"4","author":"Jacks","year":"1994","journal-title":"Curr Biol"},{"key":"key20180107220231_b17-or-38-04-1985","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/355209a0","article-title":"Carcinogens leave fingerprints","volume":"355","author":"Vogelstein","year":"1992","journal-title":"Nature"},{"key":"key20180107220231_b18-or-38-04-1985","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1126\/science.8266092","article-title":"p53: At the crossroads of molecular carcinogenesis and risk assessment","volume":"262","author":"Harris","year":"1993","journal-title":"Science"},{"key":"key20180107220231_b19-or-38-04-1985","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S1383-5742(00)00011-9","article-title":"The yeast p53 functional assay: A new tool for molecular epidemiology. Hopes and facts","volume":"462","author":"Fronza","year":"2000","journal-title":"Mutat Res"},{"issue":"D1","key":"key20180107220231_b20-or-38-04-1985","doi-asserted-by":"crossref","first-page":"D962","DOI":"10.1093\/nar\/gks1033","article-title":"The TP53 website: An integrative resource centre for the TP53 mutation database and TP53 mutant analysis","volume":"41","author":"Leroy","year":"2013","journal-title":"Nucleic Acids Res"},{"key":"key20180107220231_b21-or-38-04-1985","first-page":"4855","article-title":"Mutations in the p53 tumor suppressor gene: Clues to cancer etiology and molecular pathogenesis","volume":"54","author":"Greenblatt","year":"1994","journal-title":"Cancer Res"},{"key":"key20180107220231_b22-or-38-04-1985","volume-title":"International Agency for Research on Cancer (IARC): IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Humans: Solar and Ultraviolet Radiation","year":"1992"},{"key":"key20180107220231_b23-or-38-04-1985","first-page":"2245","article-title":"Induction of cyclobutane pyrimidine dimers, pyrimidine(6\u20134)pyrimidone photoproducts, and Dewar valence isomers by natural sunlight in normal human mononuclear cells","volume":"55","author":"Clingen","year":"1995","journal-title":"Cancer Res"},{"key":"key20180107220231_b24-or-38-04-1985","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.mrfmmm.2004.09.012","article-title":"Ultraviolet radiation-mediated damage to cellular DNA","volume":"571","author":"Cadet","year":"2005","journal-title":"Mutat Res"},{"key":"key20180107220231_b25-or-38-04-1985","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/nm1087","article-title":"Cancer genes and the pathways they control","volume":"10","author":"Vogelstein","year":"2004","journal-title":"Nat Med"},{"key":"key20180107220231_b26-or-38-04-1985","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ygeno.2008.07.005","article-title":"Design and analysis issues in genome-wide somatic mutation studies of cancer","volume":"93","author":"Parmigiani","year":"2009","journal-title":"Genomics"},{"key":"key20180107220231_b27-or-38-04-1985","doi-asserted-by":"crossref","first-page":"6660","DOI":"10.1158\/0008-5472.CAN-09-1133","article-title":"Cancer-specific high-throughput annotation of somatic mutations: Computational prediction of driver missense mutations","volume":"69","author":"Carter","year":"2009","journal-title":"Cancer Res"},{"key":"key20180107220231_b28-or-38-04-1985","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1093\/bioinformatics\/btq630","article-title":"Identifying cancer driver genes in tumor genome sequencing studies","volume":"27","author":"Youn","year":"2011","journal-title":"Bioinformatics"},{"key":"key20180107220231_b29-or-38-04-1985","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1056\/NEJMp1508811","article-title":"The path to cancer - three strikes and you're out","volume":"373","author":"Vogelstein","year":"2015","journal-title":"N Engl J Med"},{"key":"key20180107220231_b30-or-38-04-1985","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1073\/pnas.1421839112","article-title":"Only three driver gene mutations are required for the development of lung and colorectal cancers","volume":"112","author":"Tomasetti","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20180107220231_b31-or-38-04-1985","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1056\/NEJMra052166","article-title":"Melanoma","volume":"355","author":"Miller","year":"2006","journal-title":"N Engl J Med"},{"key":"key20180107220231_b32-or-38-04-1985","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1046\/j.1365-2230.2000.00693.x","article-title":"Epidemiology of melanoma","volume":"25","author":"Marks","year":"2000","journal-title":"Clin Exp Dermatol"},{"key":"key20180107220231_b33-or-38-04-1985","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/nature08658","article-title":"A comprehensive catalogue of somatic mutations from a human cancer genome","volume":"463","author":"Pleasance","year":"2010","journal-title":"Nature"},{"key":"key20180107220231_b34-or-38-04-1985","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.cell.2012.06.024","article-title":"A landscape of driver mutations in melanoma","volume":"150","author":"Hodis","year":"2012","journal-title":"Cell"},{"key":"key20180107220231_b35-or-38-04-1985","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1056\/NEJMoa1502583","article-title":"The genetic evolution of melanoma from precursor lesions","volume":"373","author":"Shain","year":"2015","journal-title":"N Engl J Med"},{"key":"key20180107220231_b36-or-38-04-1985","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/nrc.2016.37","article-title":"From melanocytes to melanomas","volume":"16","author":"Shain","year":"2016","journal-title":"Nat Rev Cancer"},{"key":"key20180107220231_b37-or-38-04-1985","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/exd.12356","article-title":"Family matters: Sibling rivalry and bonding between p53 and p63 in cancer","volume":"23","author":"Romano","year":"2014","journal-title":"Exp Dermatol"},{"key":"key20180107220231_b38-or-38-04-1985","doi-asserted-by":"crossref","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","article-title":"Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal","volume":"6","author":"Gao","year":"2013","journal-title":"Sci Signal"},{"key":"key20180107220231_b39-or-38-04-1985","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The cBio cancer genomics portal: An open platform for exploring multidimensional cancer genomics data","volume":"2","author":"Cerami","year":"2012","journal-title":"Cancer Discov"},{"key":"key20180107220231_b40-or-38-04-1985","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/nature11071","article-title":"Melanoma genome sequencing reveals frequent PREX2 mutations","volume":"485","author":"Berger","year":"2012","journal-title":"Nature"},{"key":"key20180107220231_b41-or-38-04-1985","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1038\/ng.2359","article-title":"Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma","volume":"44","author":"Krauthammer","year":"2012","journal-title":"Nat Genet"},{"key":"key20180107220231_b42-or-38-04-1985","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1002\/ajmg.a.32793","article-title":"Spectrum of p63 mutations in a selected patient cohort affected with ankyloblepharon-ectodermal defects-cleft lip\/palate syndrome (AEC)","volume":"149A","author":"Rinne","year":"2009","journal-title":"Am J Med Genet A"},{"key":"key20180107220231_b43-or-38-04-1985","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1365-2133.2009.09496.x","article-title":"Molecular basis of EEC (ectrodactyly, ectodermal dysplasia, clefting) syndrome: Five new mutations in the DNA-binding domain of the TP63 gene and genotype-phenotype correlation","volume":"162","author":"Clements","year":"2010","journal-title":"Br J Dermatol"},{"key":"key20180107220231_b44-or-38-04-1985","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/0022-2836(87)90669-3","article-title":"Statistical test for the comparison of samples from mutational spectra","volume":"194","author":"Adams","year":"1987","journal-title":"J Mol Biol"},{"key":"key20180107220231_b45-or-38-04-1985","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1093\/carcin\/15.10.2281","article-title":"Computer program for the analysis of mutational spectra: Application to p53 mutations","volume":"15","author":"Cariello","year":"1994","journal-title":"Carcinogenesis"},{"key":"key20180107220231_b46-or-38-04-1985","doi-asserted-by":"crossref","first-page":"e20643","DOI":"10.1371\/journal.pone.0020643","article-title":"p53 transactivation and the impact of mutations, cofactors and small molecules using a simplified yeast-based screening system","volume":"6","author":"Andreotti","year":"2011","journal-title":"PLoS One"},{"key":"key20180107220231_b47-or-38-04-1985","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1002\/1097-0061(20000630)16:9<857::AID-YEA561>3.0.CO;2-B","article-title":"Rapid and reliable protein extraction from yeast","volume":"16","author":"Kushnirov","year":"2000","journal-title":"Yeast"},{"key":"key20180107220231_b48-or-38-04-1985","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1126\/science.1235122","article-title":"Cancer genome landscapes","volume":"339","author":"Vogelstein","year":"2013","journal-title":"Science"},{"key":"key20180107220231_b49-or-38-04-1985","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.cell.2009.01.039","article-title":"A Mutant-p53\/Smad complex opposes p63 to empower TGFbeta-induced metastasis","volume":"137","author":"Adorno","year":"2009","journal-title":"Cell"},{"key":"key20180107220231_b50-or-38-04-1985","doi-asserted-by":"crossref","first-page":"135","DOI":"10.5021\/ad.2013.25.2.135","article-title":"Insights into the transforming growth factor-\u03b2 signaling pathway in cutaneous melanoma","volume":"25","author":"Perrot","year":"2013","journal-title":"Ann Dermatol"},{"key":"key20180107220231_b51-or-38-04-1985","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1084\/jem.20121439","article-title":"p63 is an alternative p53 repressor in melanoma that confers chemoresistance and a poor prognosis","volume":"210","author":"Matin","year":"2013","journal-title":"J Exp Med"},{"key":"key20180107220231_b52-or-38-04-1985","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1182\/blood-2013-11-539726","article-title":"Clinical impact of small TP53 mutated subclones in chronic lymphocytic leukemia","volume":"123","author":"Rossi","year":"2014","journal-title":"Blood"}],"container-title":["Oncology Reports"],"original-title":[],"language":"en","deposited":{"date-parts":[[2019,10,2]],"date-time":"2019-10-02T10:51:05Z","timestamp":1570013465000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/or.2017.5903"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":52,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2017,8,14]]},"published-print":{"date-parts":[[2017,4]]}},"alternative-id":["10.3892\/or.2017.5903"],"URL":"https:\/\/doi.org\/10.3892\/or.2017.5903","relation":{},"ISSN":["1021-335X","1791-2431"],"issn-type":[{"value":"1021-335X","type":"print"},{"value":"1791-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4]]}}}